ABSTRACT:

Diabetes mellitus has been widely-spread disorder worldwide and it causes a high level of pressure on services provided by health centers. The outcomes of patient can be greatly enhanced by early detection to overcome serious consequences. Glycated hemoglobin (HbA1c) can be utilized to evaluate blood glucose level control over the last three to six months and establish efficient therapeutic strategy. The HbA1c levels can also be utilized to control glycemic levels in pregnant women suspected with diabetes mellitus. Anyhow, by increasing usage of HbA1c in laboratory work, it has been clearly recognized that non-glycemic factors may also have impact on glycated hemoglobin. This review cast a light on the principles of detection methods, pathophysiology and clinical significance of glycated hemoglobin (HbA1c).

REFERENCES :

1) American Diabetes Association ADA (2011). Standards of medical care in diabetes–2011. Diabetes care, 34 Suppl 1(Suppl 1), S11–S61. https://doi.org/10.2337/dc11-S011
2) Ang, S. H., Thevarajah, M., Alias, Y., & Khor, S. M. (2015). Current aspects in hemoglobin A1c detection: a review. Clinica chimica acta; international journal of clinical chemistry, 439, 202–211. https://doi.org/10.1016/j.cca.2014.10.019
3) Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., & Zhou, T. (2022). Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review). Experimental and therapeutic medicine, 24(6), 707. 

https://doi.org/10.3892/etm.2022.11643
4) Colagiuri S. (2011). Glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus–practical implications. Diabetes research and clinical practice, 93(3), 312–313. https://doi.org/10.1016/j.diabres.2011.06.025
5) Gourlay, A., Sutherland, C., & Radley, A. (2023). Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing type 2 diabetes: a systematic review and meta-analysis protocol. BMJ open, 13(5), e072882. https://doi.org/10.1136/bmjopen-2023-072882
6) Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., Jovanovic, L. B., Kjos, S. I., Knopp, R. H., Montoro, M. N., Ogata, E. S., Paramsothy, P., Reader, D. M., Rosenn, B. M., Thomas, A. M., & Kirkman, M. S. (2008). Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes care, 31(5), 1060–1079. https://doi.org/10.2337/dc08-9020
7) Little, R. R., & Rohlfing, C. L. (2013). The long and winding road to optimal HbA1c measurement. Clinica chimica acta; international journal of clinical chemistry, 418, 63–71. https://doi.org/10.1016/j.cca.2012.12.026
8) Liu, L., Hood, S., Wang, Y., Bezverkov, R., Dou, C., Datta, A., & Yuan, C. (2008). Direct enzymatic assay for %HbA1c in human whole blood samples. Clinical biochemistry, 41(7-8), 576–583. https://doi.org/10.1016/j.clinbiochem.2008.01.013
9) NCD Risk Factor Collaboration (NCD-RisC) (2016). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet (London, England), 387(10027), 1513–1530. https://doi.org/10.1016/S0140-6736(16)00618-8
10) Rhea, J. M., & Molinaro, R. (2014). Pathology consultation on HbA(1c) methods and interferences. American journal of clinical pathology, 141(1), 5–16. https://doi.org/10.1309/AJCPQ23GTTMLAEVL
11) Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011). Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical chemistry, 57(6), e1–e47. https://doi.org/10.1373/clinchem.2010.161596
12) Seino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., Kasuga, M., Hanafusa, T., Haneda, M., & Ueki, K. (2010). Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Journal of diabetes investigation, 1(5), 212–228. https://doi.org/10.1111/j.2040-1124.2010.00074.x
13) Weykamp C. (2013). HbA1c: a review of analytical and clinical aspects. Annals of laboratory medicine, 33(6), 393–400. https://doi.org/10.3343/alm.2013.33.6.393
14) Weykamp, C., John, W. G., & Mosca, A. (2009). A review of the challenge in measuring hemoglobin A1c. Journal of diabetes science and technology, 3(3), 439–445. https://doi.org/10.1177/193229680900300306.